STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Moberg Derma AB (STO:MOB) has entered into a distribution agreement with Ana Darou P.J.S. for Nalox™/Emtrix® – for discolored and damaged nails caused by nail fungus (onychomycosis) or nail psoriasis. Under the agreement Ana Darou is granted exclusive rights to market and sell Nalox™/Emtrix® in Iran. Moberg Derma assumes production and supply responsibility. “The agreement is part of our international commercialization of Nalox™/Emtrix®. We are looking forward to make the product available to the patients in Iran through the cooperation with Ana Darou”, says Peter Wolpert, CEO and founder of Moberg Derma.
